As equally important, the “art” of medicine must be performed in conjunction with the science of medicine. At Genesis Cancer and Blood Institute, we have been deeply associated with the science of medicine through the capabilities of clinical trials and research for over 30 years. As our patient, this means you have immediate access to investigational treatment and supportive medications under study. Our physicians are recognized, not only nationally, but internationally as some of the top investigators in treatment trials for lung, breast, prostate, and pancreatic cancer, and supportive trials for the control of nausea and anemia during treatment. They are published in over 30 nationally recognized peer reviewed journals for their tireless work.
In general, clinical trials are used to test the safety and effectiveness of drugs and medical procedures in a human population. This ongoing collaboration between physician investigators and study volunteers is one of the foundations of modern healthcare, because clinical trials help set the standards for patient care.
There are potential benefits, as well, for clinical trial volunteers. For instance, volunteers with existing diseases or conditions can play a more active role in their own healthcare, gain access to new research treatments before they are widely available and help others by contributing to medical research.
Most clinical research that involves the testing of a new drug progresses in an orderly series of steps, called phases. This allows researchers to ask and answer questions in a way that results in reliable information about the drug and protects the patients. Most clinical trials are classified into one of three phases:
In addition, after a treatment has been approved and is being marketed, the drug's maker may study it further in a phase IV trial. The purpose of phase IV trials is to evaluate the side effects, risks, and benefits of a drug over a longer period of time and in a larger number of people than in phase III clinical trials. Thousands of people are involved in a phase IV trial.
Every clinical trial in the United States must be approved and monitored by an Institutional Review Board (IRB). An IRB is an independent committee of physicians, statisticians, community advocates and others whose objective is to ensure that a clinical trial is ethical and the rights of study participants are protected. An IRB generally includes physicians, nurses, bioethicists, attorneys, social workers and general lay people.
An IRB reviews the proposed clinical trial protocol to ascertain that the risks involved in participating in a trial are significantly outweighed by the potential benefits. Federal law stipulates that all institutions that conduct or support biomedical research involving people must have an IRB that initially approves and periodically reviews the research projects.
Federal regulations and policies protect subjects in clinical research protocols, ensuring that their safety is given the highest priority. These regulations complement the policies of academic institutions that host the GCRCs.
Research should not be considered a "last resort", as specific clinical trials are often available for a variety of cancers. Please ask your physician if there is a clinical trial available for you. If so, a clinical research professional may spend time discussing research participation with you. Participation in research is always voluntary.
Copyright 2020 Genesis Cancer and Blood Institute ® A Division of American Oncology Partners, P.A. All rights reserved